Clinical Trial Update: LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes [NA]

View source ↗

Summary

This clinical trial is currently recruiting to evaluate LN-RADS, RECIST 1.1, and Node-RADS classification methods for assessing lymph nodes in patients with lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymph Node Metastasis
• Lymph Node Neoplasm

Snippet

Sponsor: Copernicus Memorial Hospital | Conditions: Lymph Node Neoplasm, Lymph Node Metastasis | NA | Status: RECRUITING